Influencing and shaping our sector | BIA update: July - October 2019

The BioIndustry Association (BIA)’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from July to October 2019.

The BIA has been busy engaging with the new Government this quarter. We have written to key members of Prime Minister Boris Johnson’s new Cabinet and met with several ministers and special advisers to ensure the priorities of the sector remain well-understood within government. We have also increased our efforts to help life sciences companies to get ready for a potential no-deal Brexit, including holding weekly webinars and hosting regional workshops.

The party conference season is over, and as usual, the BIA team attended the conferences of the Conservative Party, Labour Party and Liberal Democrats. At the beginning of the quarter, we also published a joint report together with the Alliance for Regenerative Medicine (ARM) on the strength of the UK’s advanced therapies sector. We also hosted our annual regulatory conference, published new finance data that shows UK biotech has raised £869m so far this year, and announced a new initiative in China together with AstraZeneca. Read about all this and much more in the report.